Lit review
par
Adams, Alison et al
Date de publication
2023
Géographie
International
Langue de la ressource
English
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Oui
Évalué par des pairs
Yes
L’objectif
The COVID-19 pandemic led to an unprecedented relaxation of restrictions on take-home doses in opioid agonist treatment (OAT). We conducted a mixed methods systematic review to explore the impact of these changes on program effectiveness and client experiences in OAT.
Constatations/points à retenir
The relaxation of restrictions on take-home doses was associated with improved client experience and retention in OAT. We found no evidence of an association with illicit substance use or overdose, despite the expansion of take-home doses to previously ineligible groups.
La conception ou méthodologie de recherche
Lit review (40 studies included)
Mots clés
Carries/take-home doses
Hesitancy of prescribers
Policy/Regulatory
